Pharmaceuticals, Biotechnology and Life Sciences
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today anno…
Proceeds to support advancement of the company’s unique discovery platform and robust portfolio of programs focused on high value, traditionally undruggable targets
SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biotechnology company utili…
Virtual, placebo-controlled study indicates AppliedVR’s EaseVRx platform creates high engagement; produces “clinically meaningful” impact on five key pain indicators
LOS ANGELES–(BUSINESS WIRE)–#AppliedVR–AppliedVR, a pioneer advancing the next gen…
SAN DIEGO–(BUSINESS WIRE)–The National Science Foundation (NSF) has awarded Dr. Kiana Aran, cofounder and Chief Scientific Officer of Cardea Bio Inc., with the Faculty Early Career Development (CAREER) award. With this $549,509 grant, awarded to Dr. …
Expanded services lowers the barrier-to-entry for drug development
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#biopharma–Mispro Biotech Services, a CVO (Contract Vivarium Organization) with locations in all major U.S. biotech clusters, today anno…
DUBLIN–(BUSINESS WIRE)–The “Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design; By Indication; By Phases; By Regions; Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering.
The g…
DUBLIN–(BUSINESS WIRE)–The “Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design; By Indication; By Phases; By Regions; Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering.
The g…
ATLANTA–(BUSINESS WIRE)–Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced toda…
ATLANTA–(BUSINESS WIRE)–Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced toda…
ATLANTA–(BUSINESS WIRE)–Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced toda…